Gaceta Mexicana de Oncologia最新文献

{"title":"Paciente con enfermedad renal: manejo del dolor","authors":"Marco Antonio Narváez Tamayo ,&nbsp;Celina Castañeda de la Lanza ,&nbsp;Gabriel J. O Shea Cuevas ,&nbsp;Javier Lozano Herrera ,&nbsp;Celina Castañeda Martínez","doi":"10.1016/j.gamo.2015.12.006","DOIUrl":"https://doi.org/10.1016/j.gamo.2015.12.006","url":null,"abstract":"<div><p>The indiscriminate use of this group has contributed to increase or precipitate the incidence of patients with kidney failure. Therefore the importance of knowing this complications, in order to be able to treat, prevent and avoid this complication. This makes us considerate other group of pain killers, such as opioids, which have better analgesic effect and less impact in kidneys, this makes them versatile in various cases: like acute pain, chronic pain and breakthrough pain.</p></div>","PeriodicalId":41581,"journal":{"name":"Gaceta Mexicana de Oncologia","volume":"14 6","pages":"Pages 335-341"},"PeriodicalIF":0.1,"publicationDate":"2015-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gamo.2015.12.006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136916993","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Secuenciación en la terapéutica para tumores neuroendocrinos gastroenteropancreáticos","authors":"Enrique Grande","doi":"10.1016/j.gamo.2015.12.002","DOIUrl":"https://doi.org/10.1016/j.gamo.2015.12.002","url":null,"abstract":"","PeriodicalId":41581,"journal":{"name":"Gaceta Mexicana de Oncologia","volume":"14 6","pages":"Pages 310-312"},"PeriodicalIF":0.1,"publicationDate":"2015-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gamo.2015.12.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136916997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evolución de los pacientes con cáncer de mama que sobreexpresan el receptor del factor de crecimiento epidérmico humano (HER2/Neu) en el Hospital del Instituto de Seguridad y Servicio Social de los Trabajadores al Servicio de los Poderes del Estado de Puebla (ISSSTEP)","authors":"Eduardo Téllez Bernal,&nbsp;Alma Mendoza López,&nbsp;Jacinto Christian Alonso Martínez,&nbsp;Fernando Silva Bravo,&nbsp;Luis Sánchez Brito,&nbsp;Yareni Pérez Lozano","doi":"10.1016/j.gamo.2015.12.004","DOIUrl":"https://doi.org/10.1016/j.gamo.2015.12.004","url":null,"abstract":"<div><h3>Purpose</h3><p>The purpose of this review is to know the evolution of the patients who were treated in hospital ISSSTEP with breast cancer. Most of them received trastuzumab, either adjuvant or for the treatment of metastatic disease.</p></div><div><h3>Methods</h3><p>We take into account the patients expressed about HER2/Neu gene, either by immunohistochemistry or FISH, with the criteria of age, clinical stage, and the evolution of his illness. This review covers the year 2009 by the end of 2014.</p></div><div><h3>Results</h3><p>The patients with breast cancer were reported 238, of which 187 collect HER2/Neu negative, and 51 patients with HER2/Neu positive. Patients who developed metastases, either at the beginning of his illness, or as part of their recurrence were 37 in total, with 26 for the HER2/Neu negative group and 11 for the HER2/Neu positive group. The metastatic sites of HER2/Neu positive patients were: 5 in central nervous system, 5 to skin, 4 to lung, 3 to bone, and 2 to liver.</p></div><div><h3>Conclusion</h3><p>Our group, indicates that the most common site of metastasis is the central nervous system and skin. Based on this experience we believe that patients who over-express HER2/Neu should have baseline brain scans, and their developments as well as neurological symptoms should be closely monitored, or perform periodic scans to detect early metastasis.</p></div>","PeriodicalId":41581,"journal":{"name":"Gaceta Mexicana de Oncologia","volume":"14 6","pages":"Pages 319-322"},"PeriodicalIF":0.1,"publicationDate":"2015-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gamo.2015.12.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136917385","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Discurso de bienvenida al XXXIII Congreso Nacional de Oncología, de la Sociedad Mexicana de Oncología (SMeO)","authors":"Laura Torrecillas Torres","doi":"10.1016/j.gamo.2015.11.010","DOIUrl":"https://doi.org/10.1016/j.gamo.2015.11.010","url":null,"abstract":"","PeriodicalId":41581,"journal":{"name":"Gaceta Mexicana de Oncologia","volume":"14 6","pages":"Pages 303-304"},"PeriodicalIF":0.1,"publicationDate":"2015-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gamo.2015.11.010","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136917388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Riñón supernumerario con carcinoma de células claras","authors":"Victor González Tejeda ,&nbsp;Ismael Padilla Ponce ,&nbsp;Lizeth Vázquez ,&nbsp;Victor Antonio Sevilla Lizcano ,&nbsp;José Manuel Rentería Navarro ,&nbsp;Francisco Bolio Laviada","doi":"10.1016/j.gamo.2015.12.007","DOIUrl":"https://doi.org/10.1016/j.gamo.2015.12.007","url":null,"abstract":"<div><p>The incidence of congenital anomalies of urinary tract and kidney is 0.3 to 1.6 per 1000 births, the incidence is higher among women, particularly those with a family history. The supernumerary kidney is the rarest of kidney malformations and usually is discovered incidentally or when presented with complications. The clear cell carcinoma represents 80 to 85% of primary malignant tumors of kidney. However, the presence of both at the same time, ie, renal cell carcinoma in a supernumerary kidney and with ectopic location, is an extremely unusual condition, so we are notifying a case.</p></div>","PeriodicalId":41581,"journal":{"name":"Gaceta Mexicana de Oncologia","volume":"14 6","pages":"Pages 359-362"},"PeriodicalIF":0.1,"publicationDate":"2015-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gamo.2015.12.007","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136916990","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Reintegración del niño con cáncer en la escuela","authors":"Sandra Flor Páez Aguirre","doi":"10.1016/j.gamo.2015.11.012","DOIUrl":"https://doi.org/10.1016/j.gamo.2015.11.012","url":null,"abstract":"<div><p>Children and adolescents with cancer, excepting some with central nervous system tumors, have the same cognitive capacity that their peers, early reintegration, tell them that they have a future, growth and development potencial. After hospitalization the school is a normalized factor, it reinforcement the hope in cure. Many factors should be taken to reach appropiated schoolar environment; teachers, parents and classmates have been informated about children medical situation. Children and adolescents with cancer need to be seen like students, not like patients.</p></div>","PeriodicalId":41581,"journal":{"name":"Gaceta Mexicana de Oncologia","volume":"14 6","pages":"Pages 342-345"},"PeriodicalIF":0.1,"publicationDate":"2015-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gamo.2015.11.012","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136916992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Guías de Práctica Clínica Basadas en Evidencia, cerrando la brecha entre el conocimiento científico y la toma de decisiones clínicas. Documento de la serie MBE, 3 de 3","authors":"José Luis Mayorga Butrón ,&nbsp;Liliana Velasco Hidalgo ,&nbsp;Francisco Javier Ochoa-Carrillo","doi":"10.1016/j.gamo.2015.12.005","DOIUrl":"https://doi.org/10.1016/j.gamo.2015.12.005","url":null,"abstract":"<div><h3>Introduction</h3><p>Evidence-Based Clinical Practice Guidelines (CPGs) contain recommendations to assist practitioners, patients and other health professionals in their clinical decisions in order to achieve better healthcare.</p></div><div><h3>Material and methods</h3><p>Narrative review. The purpose of this work is to describe the CPGs fundamentals and the steps to develop them.</p></div><div><h3>Results</h3><p>CPGs contain recommendations result of a systematic work of a development group integrated by clinical and methodological experts, stakeholder and patients representatives. The protocol includes the scope, a list of clinical structured questions and systematic reviews to find, assess and extract evidence. An expert consensus panel methodology is also considered in order to integrated expertise to the existent scientific evidence.</p></div><div><h3>Conclusion</h3><p>CPGs aim is to bridge the gap between scientific evidence and clinical decision-making through clinical recommendations systematically developed. This is the third document of a series of literature review that has been written to aware about the value of CPGs and the importance that clinical oncologists and researchers adopt and develop such documents in our country and worldwide.</p></div>","PeriodicalId":41581,"journal":{"name":"Gaceta Mexicana de Oncologia","volume":"14 6","pages":"Pages 329-334"},"PeriodicalIF":0.1,"publicationDate":"2015-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gamo.2015.12.005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136916994","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"In memoriam del «Dr. Arturo Dagoberto Beltrán Ortega»","authors":"Francisco Javier Ochoa Carrillo","doi":"10.1016/j.gamo.2015.12.001","DOIUrl":"https://doi.org/10.1016/j.gamo.2015.12.001","url":null,"abstract":"","PeriodicalId":41581,"journal":{"name":"Gaceta Mexicana de Oncologia","volume":"14 6","pages":"Pages 305-306"},"PeriodicalIF":0.1,"publicationDate":"2015-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gamo.2015.12.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136917387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Explorando el conocimiento de los médicos y su actitud en pacientes pediátricos en cuidados paliativos","authors":"Fabiola Sánchez ,&nbsp;Miguel Palomo ,&nbsp;Osvaldo Daniel Castelán-Martínez ,&nbsp;Jose Felix Gaytan ,&nbsp;Ivan Castorena ,&nbsp;Víctor Olivar","doi":"10.1016/j.gamo.2015.11.014","DOIUrl":"https://doi.org/10.1016/j.gamo.2015.11.014","url":null,"abstract":"<div><h3>Introduction</h3><p>Terminal disease is manifesting as an advanced, progressive and incurable disease with no response to treatment with specific multifactorial symptoms and prognosis of no more than 6 months.</p></div><div><h3>Methods</h3><p>A cross-sectional survey was conducted to evaluate the concepts of terminal disease in a tertiary care, 5 cases were included, 3 of them with criteria for terminal illness, statistical analysis was performed to analyze differences according to the characteristics participants using Chi square test.</p></div><div><h3>Results</h3><p>112 physicians included, where terminals are classified as the correlation diagnostic trouble therapy.</p></div><div><h3>Conclusion</h3><p>Actions are needed to enable the medical staff to improve care in patients with terminal illnesses in children.</p></div>","PeriodicalId":41581,"journal":{"name":"Gaceta Mexicana de Oncologia","volume":"14 6","pages":"Pages 353-358"},"PeriodicalIF":0.1,"publicationDate":"2015-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gamo.2015.11.014","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136916991","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Supervivencia global en pacientes con cáncer gástrico avanzado o metastásico en los últimos 10 años en el Centro Médico Nacional «20 de noviembre del ISSSTE»","authors":"Denisse Añorve B. ,&nbsp;Fernando Aldaco S. ,&nbsp;Perla Pérez P. ,&nbsp;Laura Torrecillas T. ,&nbsp;M. Guadalupe Cervantes S. ,&nbsp;Aura A. Erazo Valle Solis ,&nbsp;Nora Sobrevilla M. ,&nbsp;Alexandro Martínez G. ,&nbsp;Raúl Lugo Villegas","doi":"10.1016/j.gamo.2015.12.003","DOIUrl":"https://doi.org/10.1016/j.gamo.2015.12.003","url":null,"abstract":"<div><h3>Background</h3><p>The introduction of new drugs for the treatment of patients with advanced, recurrent or metastatic gastric cancer has resulted in a small benefit in overall survival (OS) and progression free survival (PFS).</p></div><div><h3>Objective</h3><p>To determine the impact of new chemotherapy schedules on the OS of patients with advanced or metastic gastric cancer treated at the Centro Medico Nacional 20 de noviembre, ISSSTE.</p></div><div><h3>Material and methodology</h3><p>Retrolective, descriptive study, the clinical files of patients with advanced, recurrent or metastatic gastric cancer treated with chemotherapy at the Centro Medico Nacional 20 de noviembre, ISSSTE, from january 2002 to december 2012, were analyzed. Chemotherapy schedules, OS and PFS were evaluated. Patients were assigned to two cohorts: those treated from january 2002 to december 2006 were included in cohort A and those treated from january 2007 to december 2012 in cohort B. These time periods were determined based on the years when newer chemotherapy agents (anthracyclines, oxaliplatin, capecitabine and docetaxel) were introduced in our institution.</p></div><div><h3>Results</h3><p>291 clinical files were analyzed; 221 patients were excluded for they had clinical stage I, II or resectable III disease, started first line chemotherapy as outpatients of our institution or were not candidates for chemotherapy. 70 cases treated with first line chemotherapy were included. OS for patients in cohort A was 11.2 months vs 10.5 months for patients in cohort B. PFS was 8.5 months vs 5.2, respectively. There was no statistical difference in either comparison.</p></div><div><h3>Conclusion</h3><p>There was no impact of the introduction of newer chemotherapy agents in OS or PFS in patients treated in our institution. A small sample size and the fact that patients with poor performance status received chemotherapy could have had influenced the results of our study, in which tendency towards a better outcome for patients treated with newer chemotherapy schemes was observed, although a statistically significant benefit was not proven.</p></div>","PeriodicalId":41581,"journal":{"name":"Gaceta Mexicana de Oncologia","volume":"14 6","pages":"Pages 313-318"},"PeriodicalIF":0.1,"publicationDate":"2015-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gamo.2015.12.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136916996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}